By Dr. Sam Bailey and the Health Freedom Defense Fund Pfizer, a globally recognized pharmaceutical titan, has an impressive track record of developing key medications. However, beneath these accomplishments lurks a murkier reality, marked by legal battles hinting at questionable business ethics and corruption. In 2009, Pfizer was slapped with a hefty fine of US$2.3 […]
Related Posts
Ibovespa Declines Amid Anticipation of Petrobras Financials
On Thursday, the Ibovespa, Brazil’s benchmark stock index, dropped by 0.43%, closing at 129,339 points. This decline occurred despite a notable 1.80% increase in iron ore prices and uplifts in New York’s stock exchanges. The fall was notably influenced by Petrobras (PETR4) shares, which decreased by 1.10% due to the international downturn in oil prices. […]
China’s Economic Growth Slows to 4.6% Amid Real Estate Woes
China’s economy grew by 4.6% in the third quarter of 2024 compared to the same period in 2023. This growth rate, while significant, marks the slowest pace since the first quarter of 2023. The Chinese government has set an annual growth target of about 5%, which now seems challenging to achieve. Industrial production increased by […]
Brazil’s Auto Industry Sees Major Boost
President Luiz Inácio Lula da Silva met with top executives from BYD and General Motors (GM), announcing a R$10 billion ($2 billion) investment in Brazil. These talks in Brasilia highlighted Brazil’s growing electric vehicle (EV) market and its role in automotive innovation and eco-friendly development. The meeting started at Alvorada Palace with BYD, marking its […]